Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 440.07 Billion JPY | 51.61% |
| 2023 | 383.57 Billion JPY | 17.43% |
| 2022 | 326.63 Billion JPY | 1.08% |
| 2021 | 323.15 Billion JPY | -5.78% |
| 2020 | 342.95 Billion JPY | -15.84% |
| 2019 | 407.52 Billion JPY | 2.7% |
| 2018 | 396.82 Billion JPY | 8.19% |
| 2017 | 366.77 Billion JPY | -14.71% |
| 2016 | 430.01 Billion JPY | 7.8% |
| 2015 | 398.88 Billion JPY | 8.69% |
| 2014 | 367.01 Billion JPY | 6.96% |
| 2013 | 343.12 Billion JPY | -1.48% |
| 2012 | 348.28 Billion JPY | -0.29% |
| 2011 | 349.3 Billion JPY | 0.35% |
| 2010 | 348.09 Billion JPY | -18.41% |
| 2009 | 426.63 Billion JPY | 7.5% |
| 2008 | 396.85 Billion JPY | 12.89% |
| 2007 | 351.55 Billion JPY | 18.89% |
| 2006 | 295.7 Billion JPY | 7.95% |
| 2005 | 273.91 Billion JPY | 16.28% |
| 2004 | 235.57 Billion JPY | 13.0% |
| 2003 | 208.46 Billion JPY | 17.45% |
| 2002 | 177.49 Billion JPY | 11.1% |
| 2001 | 159.76 Billion JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 440.07 Billion JPY | 14.73% |
| 2024 Q1 | 108.77 Billion JPY | -4.97% |
| 2024 Q3 | 119.27 Billion JPY | 5.68% |
| 2024 Q2 | 112.86 Billion JPY | 3.76% |
| 2024 Q4 | 132.32 Billion JPY | 10.94% |
| 2023 Q2 | 102.51 Billion JPY | -5.87% |
| 2023 Q1 | 108.91 Billion JPY | -2.56% |
| 2023 FY | 383.57 Billion JPY | 17.43% |
| 2023 Q4 | 114.46 Billion JPY | 6.43% |
| 2023 Q3 | 107.55 Billion JPY | 4.91% |
| 2022 Q1 | 95.62 Billion JPY | -10.45% |
| 2022 Q3 | 102.16 Billion JPY | 6.79% |
| 2022 Q4 | 111.78 Billion JPY | 9.42% |
| 2022 FY | 326.63 Billion JPY | 1.08% |
| 2022 Q2 | 95.66 Billion JPY | 0.03% |
| 2021 Q2 | 84.17 Billion JPY | 3.19% |
| 2021 Q1 | 81.57 Billion JPY | -28.32% |
| 2021 Q4 | 106.78 Billion JPY | 14.55% |
| 2021 FY | 323.15 Billion JPY | -5.78% |
| 2021 Q3 | 93.22 Billion JPY | 10.74% |
| 2020 Q2 | 91.1 Billion JPY | -10.74% |
| 2020 FY | 342.95 Billion JPY | -15.84% |
| 2020 Q3 | 96.1 Billion JPY | 5.5% |
| 2020 Q4 | 113.8 Billion JPY | 18.42% |
| 2020 Q1 | 102.06 Billion JPY | -17.5% |
| 2019 Q2 | 116.09 Billion JPY | -10.68% |
| 2019 Q1 | 129.98 Billion JPY | 11.64% |
| 2019 Q4 | 123.72 Billion JPY | 10.38% |
| 2019 FY | 407.52 Billion JPY | 2.7% |
| 2019 Q3 | 112.09 Billion JPY | -3.45% |
| 2018 Q3 | 108.82 Billion JPY | 4.47% |
| 2018 FY | 396.82 Billion JPY | 8.19% |
| 2018 Q1 | 99.99 Billion JPY | -13.66% |
| 2018 Q4 | 116.43 Billion JPY | 7.0% |
| 2018 Q2 | 104.16 Billion JPY | 4.17% |
| 2017 Q3 | 98.14 Billion JPY | 4.55% |
| 2017 Q2 | 93.87 Billion JPY | -3.61% |
| 2017 FY | 366.77 Billion JPY | -14.71% |
| 2017 Q1 | 97.39 Billion JPY | -11.98% |
| 2017 Q4 | 115.81 Billion JPY | 18.01% |
| 2016 FY | 430.01 Billion JPY | 7.8% |
| 2016 Q2 | 108.12 Billion JPY | 3.39% |
| 2016 Q1 | 104.57 Billion JPY | -5.38% |
| 2016 Q4 | 110.64 Billion JPY | 2.99% |
| 2016 Q3 | 107.43 Billion JPY | -0.64% |
| 2015 FY | 398.88 Billion JPY | 8.69% |
| 2015 Q2 | 95.64 Billion JPY | 4.73% |
| 2015 Q3 | 101.39 Billion JPY | 6.01% |
| 2015 Q1 | 91.32 Billion JPY | -8.3% |
| 2015 Q4 | 110.52 Billion JPY | 9.0% |
| 2014 Q2 | 90.43 Billion JPY | 5.25% |
| 2014 Q3 | 91.06 Billion JPY | 0.69% |
| 2014 Q4 | 99.58 Billion JPY | 9.36% |
| 2014 FY | 367.01 Billion JPY | 6.96% |
| 2014 Q1 | 85.92 Billion JPY | -7.45% |
| 2013 Q2 | 84.86 Billion JPY | 0.39% |
| 2013 Q4 | 92.84 Billion JPY | 14.78% |
| 2013 Q3 | 80.88 Billion JPY | -4.68% |
| 2013 Q1 | 84.52 Billion JPY | -6.83% |
| 2013 FY | 343.12 Billion JPY | -1.48% |
| 2012 Q2 | 86.63 Billion JPY | 2.42% |
| 2012 Q1 | 84.59 Billion JPY | -8.85% |
| 2012 Q3 | 85.57 Billion JPY | -1.23% |
| 2012 Q4 | 90.72 Billion JPY | 6.02% |
| 2012 FY | 348.28 Billion JPY | -0.29% |
| 2011 Q1 | 85.68 Billion JPY | -4.31% |
| 2011 Q2 | 88.74 Billion JPY | 3.58% |
| 2011 FY | 349.3 Billion JPY | 0.35% |
| 2011 Q4 | 92.8 Billion JPY | 9.17% |
| 2011 Q3 | 85 Billion JPY | -4.21% |
| 2010 Q1 | 84.44 Billion JPY | -11.57% |
| 2010 FY | 348.09 Billion JPY | -18.41% |
| 2010 Q3 | 84.26 Billion JPY | -6.21% |
| 2010 Q4 | 89.53 Billion JPY | 6.26% |
| 2010 Q2 | 89.84 Billion JPY | 6.41% |
| 2009 FY | 426.63 Billion JPY | 7.5% |
| 2009 Q4 | 95.48 Billion JPY | -4.59% |
| 2009 Q3 | 100.08 Billion JPY | -18.86% |
| 2009 Q2 | 123.34 Billion JPY | 14.51% |
| 2009 Q1 | 107.72 Billion JPY | 0.0% |
| 2008 FY | 396.85 Billion JPY | 12.89% |
| 2007 FY | 351.55 Billion JPY | 18.89% |
| 2006 FY | 295.7 Billion JPY | 7.95% |
| 2005 FY | 273.91 Billion JPY | 16.28% |
| 2004 FY | 235.57 Billion JPY | 13.0% |
| 2003 FY | 208.46 Billion JPY | 17.45% |
| 2002 FY | 177.49 Billion JPY | 11.1% |
| 2001 FY | 159.76 Billion JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -15369293.716% |
| Ansell Limited | 495.5 Million USD | -88714.531% |
| Ansell Limited | 495.5 Million USD | -88714.531% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -531368.459% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -25426707.707% |
| Psykey, Inc. | 1.21 Million USD | -36265516.244% |
| ConvaTec Group Plc | 910.31 Million USD | -48243.225% |
| ConvaTec Group Plc | 872.5 Million USD | -50338.51% |
| Encision Inc. | 3.77 Million USD | -11652156.109% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -310325615.213% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -400320100.853% |
| Innovative MedTech Inc. | 6.09 Million USD | -7215442.349% |
| LifePoint, Inc. | 7.42 Million USD | -5927751.646% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -6931322.271% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -51470777.193% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -60605242.816% |
| Reflect Scientific, Inc. | 1.06 Million USD | -41372130.302% |
| SmileDirectClub, Inc. | 517 Million USD | -85020.589% |
| Sector 10, Inc. | 39.84 Thousand USD | -1104497440.408% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -6524.625% |
| SheerVision, Inc. | 2.33 Million USD | -18874037.676% |
| United Health Products, Inc. | 2.42 Million USD | -18135854.131% |
| Vasamed, Inc. | 4.67 Million USD | -9417492.534% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -17178263.372% |
| Yubo International Biotech Limited | 1.25 Million USD | -34985570.277% |